Exploring Differentially Methylated Genes in Vulvar Squamous Cell Carcinoma

Area of Science:

• Epigenetics
• Cancer Genomics
• Molecular Biology

Background:

• DNA methylation is a key epigenetic mechanism influencing gene expression without altering DNA sequences.
• Aberrant DNA methylation is implicated in carcinogenesis, with methylation profiling aiding cancer biomarker discovery.
• Methylation profiling in vulvar squamous cell carcinoma (VSCC) remains an under-explored area.

Purpose of the Study:

• To identify differentially methylated genes (DMGs) in primary VSCC.
• To explore the role of DNA methylation in VSCC development.
• To lay the groundwork for epigenetic profiling in VSCC.

Main Methods:

• Infinium MethylationEPIC BeadChip array sequencing was performed on 18 primary VSCC samples and 6 normal vulvar tissue samples.
• Statistical cut-offs included a false-discovery rate of 0.05, beta-difference (Δβ) of ±0.5, and CpG-island probes.
• Bioinformatic analysis identified differentially methylated genes (DMGs).

Main Results:

• 199 DMGs were identified in VSCC, with 195 hyper-methylated and 4 hypo-methylated.
• The majority of hyper-methylated genes were associated with transcription regulator activity, suggesting its role in VSCC.
• Chromosomal amplifications in chromosomes 3, 8, and 9 were observed in most VSCC samples.

Conclusions:

• This study identified a set of DMGs in VSCC, contributing to the understanding of its epigenetic landscape.
• Disruption of transcription regulation appears to be a significant factor in VSCC pathogenesis.
• Further research is needed to explore the prognostic relevance of these DMGs in larger VSCC cohorts.